By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Hanmi Pharmaceutical, Co., Ltd 

45, Bandi-dong, Songpa-gu

Seoul    138-724  Korea
Phone: +82-31-371-5027 Fax: +82-31-371-5006


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Hanmi Pharma: Efpeglenatide (GLP-1 Analog), The Promising Potential For Anti-Diabetes/Anti-Obesity Treatment As Once Weekly Up To Once Monthly 6/8/2015 10:39:21 AM
Hanmi Pharma : Once-Weekly Insulin Combination, ‘LAPSInsulin Combo’, Suggests A New Diabetes Therapeutic Option 6/8/2015 10:18:32 AM
Hanmi Pharma To Present Its New Diabetes Drugs Including Quantum Project At 2015 American Diabetes Association Scientific Sessions 6/3/2015 8:57:19 AM
ASCO15: Hanmi Pharma ‘HM61713’ Demonstrated The Effect Of Tumor Volume Reduction 6/1/2015 3:04:35 PM
PlasmaTech Biopharmaceuticals' Partner Hanmi Pharma Receives Marketing Approval For MuGard In Korea 3/31/2015 7:04:16 AM
Eli Lilly (LLY), Hanmi Pharma Forge $690 Million Autoimmune Pact 3/19/2015 7:08:24 AM
Hanmi Pharmaceutical, Co., Ltd To Assign The Rights Of The Indian Territory To Kinex Pharmaceuticals As Part Of The Orascovery Program Strategic Plan 3/9/2015 10:48:36 AM
Spectrum Pharmaceuticals, Inc. (SPPI) In-Licenses Poziotinib, A Novel pan-HER Inhibitor With Clinical Activity In Several Solid Tumors, From Hanmi Pharmaceutical, Co., Ltd 3/4/2015 11:00:53 AM
Allegro Ophthalmics LLC And Hanmi Pharmaceutical, Co., Ltd Announce Strategic Investment And Collaboration To Develop And Market Luminate® In The Republic Of Korea And China 1/13/2015 10:41:33 AM
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results From A Phase I Clinical Study (HM-OTE-103) With Oratecan® In Patients With Advanced Cancer 10/15/2014 7:56:26 AM
123
//-->